Loading...

Teva Pharmaceutical Industries Limited Peer Comparison

Metric Value Ranking
Market Cap $18.4 Billion 3/13 ZTS
$70.5B
TAK
$42.9B
TEVA
$18.4B
VTRS
$12.9B
CTLT
$11.5B
ELAN
$5.6B
BHC
$2.3B
TLRY
$872.0M
CRON
$753.1M
SNDL
$493.8M
ACB
$346.3M
CGC
$320.5M
HEXO
$31.2M
Gross Margin 50% 4/13 BHC
99%
ZTS
69%
TAK
66%
TEVA
50%
ELAN
39%
VTRS
39%
ACB
33%
CGC
30%
TLRY
29%
SNDL
27%
CTLT
18%
CRON
8%
HEXO
-43%
Profit Margin -5% 7/13 ELAN
35%
ZTS
25%
CRON
18%
TAK
8%
VTRS
3%
BHC
-3%
TEVA
-5%
SNDL
-8%
CTLT
-13%
ACB
-38%
TLRY
-40%
CGC
-100%
HEXO
-100%
EBITDA margin 6% 5/13 ZTS
39%
TAK
32%
BHC
13%
CRON
12%
TEVA
6%
VTRS
6%
CTLT
5%
ELAN
0%
SNDL
-1%
ACB
-3%
TLRY
-20%
CGC
-62%
HEXO
-137%
Quarterly Revenue $4.2 Billion 2/13 TAK
$8.2B
TEVA
$4.2B
VTRS
$3.7B
BHC
$2.5B
ZTS
$2.3B
ELAN
$1.0B
CTLT
$1.0B
TLRY
$211.0M
SNDL
$178.1M
CGC
$74.0M
ACB
$56.5M
CRON
$46.6M
HEXO
$16.2M
Quarterly Earnings -$217.0 Million 13/13 TAK
$644.1M
ZTS
$581.0M
ELAN
$364.0M
VTRS
$94.8M
CRON
$8.3M
SNDL
-$14.5M
ACB
-$21.3M
BHC
-$85.0M
TLRY
-$85.3M
HEXO
-$88.1M
CGC
-$128.3M
CTLT
-$129.0M
TEVA
-$217.0M
Quarterly Free Cash Flow $446.0 Million 4/13 TAK
$1.3B
VTRS
$750.5M
ZTS
$689.0M
TEVA
$446.0M
BHC
$341.8M
ELAN
$120.0M
SNDL
$14.0M
CTLT
$4.0M
CRON
-$0
HEXO
-$407,519
TLRY
-$40.7M
CGC
-$71.4M
ACB
-$0
Trailing 4 Quarters Revenue $16.5 Billion 2/13 TAK
$31.8B
TEVA
$16.5B
VTRS
$15.0B
BHC
$9.5B
ZTS
$9.3B
ELAN
$4.5B
CTLT
$4.4B
SNDL
$685.1M
TLRY
$671.3M
CGC
$371.4M
CRON
$146.7M
ACB
$139.9M
HEXO
$93.3M
Trailing 4 Quarters Earnings -$1.6 Billion 13/13 TAK
$8.2B
TEVA
$4.2B
VTRS
$3.7B
BHC
$2.5B
ZTS
$2.3B
ELAN
$1.0B
CTLT
$1.0B
TLRY
$211.0M
SNDL
$178.1M
CGC
$74.0M
ACB
$56.5M
CRON
$46.6M
HEXO
$16.2M
Quarterly Earnings Growth -147% 12/13 CRON
608%
TAK
292%
ELAN
133%
ACB
95%
CTLT
82%
BHC
78%
HEXO
19%
ZTS
11%
SNDL
11%
VTRS
-71%
TLRY
-85%
TEVA
-147%
CGC
-57740%
Annual Earnings Growth -334% 13/13 BHC
185%
ELAN
115%
ACB
96%
HEXO
88%
CGC
83%
CTLT
58%
TAK
32%
ZTS
7%
SNDL
7%
TLRY
-2%
CRON
-77%
VTRS
-179%
TEVA
-334%
Quarterly Revenue Growth -5% 11/13 CGC
56634%
ACB
50%
CRON
37%
TAK
13%
BHC
12%
TLRY
9%
ZTS
5%
CTLT
4%
SNDL
0%
ELAN
-4%
TEVA
-5%
VTRS
-5%
HEXO
-53%
Annual Revenue Growth 3% 8/13 CRON
61%
CGC
12%
BHC
8%
TAK
8%
ZTS
7%
CTLT
6%
ELAN
5%
TEVA
3%
VTRS
-4%
SNDL
-6%
TLRY
-7%
ACB
-8%
HEXO
-39%
Cash On Hand $3.3 Billion 2/13 TAK
$6.0B
TEVA
$3.3B
ZTS
$2.0B
VTRS
$1.9B
CRON
$862.0M
BHC
$719.0M
ELAN
$490.0M
CTLT
$335.0M
CGC
$228.4M
SNDL
$197.7M
TLRY
$189.7M
ACB
$118.7M
HEXO
$15.0M
Short Term Debt $1.8 Billion 2/13 TAK
$4.4B
TEVA
$1.8B
VTRS
$1.4B
ZTS
$1.4B
BHC
$453.0M
CGC
$137.9M
HEXO
$134.4M
CTLT
$61.0M
ACB
$59.7M
ELAN
$44.0M
TLRY
$40.2M
SNDL
$26.0M
CRON
$980,000
Long Term Debt $16.3 Billion 3/13 TAK
$31.0B
BHC
$21.1B
TEVA
$16.3B
VTRS
$16.2B
ZTS
$5.4B
CTLT
$4.9B
ELAN
$4.3B
CGC
$415.9M
TLRY
$333.6M
SNDL
$92.5M
ACB
$57.8M
CRON
$872,000
HEXO
$797,744
PE -1.00 5/13 ZTS
28.37
ELAN
27.13
TAK
21.15
BHC
8.84
TEVA
-1.00
CRON
-1.00
CTLT
-1.00
ACB
-1.00
CGC
-1.00
HEXO
-1.00
SNDL
-1.00
TLRY
-1.00
VTRS
-1.00
PS 1.11 8/13 TAK
192.82
ZTS
7.62
CRON
5.13
ACB
3.29
CTLT
2.60
TLRY
1.30
ELAN
1.25
TEVA
1.11
SNDL
0.96
CGC
0.86
VTRS
0.86
HEXO
0.45
BHC
0.24
PB 3.22 3/13 ZTS
14.79
CTLT
3.25
TEVA
3.22
ACB
0.91
TAK
0.89
ELAN
0.85
CRON
0.67
VTRS
0.65
CGC
0.63
SNDL
0.54
HEXO
0.29
TLRY
0.25
BHC
0.00
PC 5.58 6/13 ZTS
35.53
CTLT
34.40
ELAN
11.35
TAK
7.14
VTRS
6.86
TEVA
5.58
TLRY
4.60
BHC
3.15
ACB
2.92
SNDL
2.50
HEXO
2.08
CGC
1.40
CRON
0.87
Liabilities to Equity 6.25 1/13 TEVA
6.25
ZTS
1.98
HEXO
1.78
CTLT
1.74
CGC
1.42
VTRS
1.26
TAK
1.11
ELAN
1.04
ACB
0.68
TLRY
0.21
SNDL
0.18
CRON
0.05
BHC
0.00
ROA -0.04 6/13 ZTS
17%
ELAN
2%
BHC
1%
TAK
0%
VTRS
-2%
TEVA
-4%
CRON
-4%
CTLT
-4%
TLRY
-5%
SNDL
-6%
ACB
-13%
HEXO
-52%
CGC
-88%
ROE -0.30 11/13 ZTS
52%
ELAN
3%
TAK
0%
CRON
-4%
VTRS
-4%
TLRY
-6%
SNDL
-7%
CTLT
-12%
BHC
-22%
ACB
-23%
TEVA
-30%
HEXO
-144%
CGC
-212%
Current Ratio 1.17 12/13 CRON
22.42
SNDL
6.60
TLRY
5.68
ACB
2.57
ELAN
1.96
TAK
1.90
VTRS
1.79
CGC
1.71
CTLT
1.57
HEXO
1.56
ZTS
1.50
TEVA
1.17
BHC
0.99
Quick Ratio 0.10 8/13 ZTS
28.37
ELAN
27.13
TAK
21.15
BHC
8.84
TEVA
-1.00
CRON
-1.00
CTLT
-1.00
ACB
-1.00
CGC
-1.00
HEXO
-1.00
SNDL
-1.00
TLRY
-1.00
VTRS
-1.00
Long Term Debt to Equity 3.03 1/13 TEVA}
3.03
CTLT}
1.38
ZTS}
1.13
CGC}
0.82
VTRS}
0.82
ELAN}
0.66
TAK}
0.64
ACB}
0.16
SNDL}
0.10
TLRY}
0.10
HEXO}
0.01
CRON}
0.00
BHC}
-17.93
Debt to Equity 3.36 1/13 TEVA
3.36
ZTS
1.41
CTLT
1.40
HEXO
1.26
CGC
1.09
VTRS
0.89
TAK
0.73
ELAN
0.67
ACB
0.33
SNDL
0.13
TLRY
0.11
CRON
0.00
BHC
-18.32
Burn Rate 2.51 4/13 SNDL
9.36
ACB
3.57
TAK
2.58
TEVA
2.51
VTRS
2.06
TLRY
1.75
CGC
1.27
CTLT
0.99
BHC
0.69
HEXO
0.15
ELAN
-2.71
ZTS
-71.56
CRON
-106.83
Cash to Cap 0.18 8/13 CRON
1.14
CGC
0.71
HEXO
0.48
SNDL
0.40
ACB
0.34
BHC
0.32
TLRY
0.22
TEVA
0.18
VTRS
0.15
TAK
0.14
ELAN
0.09
ZTS
0.03
CTLT
0.03
CCR -2.06 11/13 VTRS
7.92
TAK
2.05
ZTS
1.19
CGC
0.56
TLRY
0.48
ELAN
0.33
CRON
0.00
HEXO
0.00
CTLT
-0.03
SNDL
-0.97
TEVA
-2.06
BHC
-4.02
ACB
EV to EBITDA 127.22 2/13 CTLT}
288.11
TEVA}
127.22
VTRS}
126.74
ZTS}
83.11
BHC}
72.50
TAK}
11.02
HEXO}
-6.22
CGC}
-14.06
CRON}
-18.74
TLRY}
-25.50
SNDL}
-130.88
ACB}
-132.10
ELAN}
-1885.69
EV to Revenue 2.01 6/13 TAK
131.78
ZTS
8.13
CTLT
3.64
BHC
2.44
ELAN
2.12
TEVA
2.01
HEXO
1.96
VTRS
1.91
ACB
1.85
CGC
1.74
TLRY
1.57
SNDL
0.39
CRON
-0.73